Q5106 is a valid 2023 HCPCS Code that could be used to indicate Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units for reimbursement purposes.
Q5106 belongs to Other Medical Items or Services Type of Service and has been in effect since Jan 01, 2020.
Inj retacrit non-esrd use
Q5106 code information
| HCPCS code: | Q5106 |
| Description: | INJECTION, EPOETIN ALFA-EPBX, BIOSIMILAR, (RETACRIT) (FOR NON-ESRD USE), 1000 UNITS |
| Effective Date: | Jan 01, 2020 |
| Added Date: | Jul 01, 2018 |
| Termination Date: | HCPCS Q5106 was terminated on Nov 30, -0001 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
9 - OTHER MEDICAL ITEMS OR SERVICES
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to Q5106